Serum bioactive lactogenic hormone levels in women with familial breast cancer and their relatives.
Serum levels of bioactive lactogenic hormone (BLH), immunoreactive prolactin and growth hormone (ir-PRL and ir-GH) were measured in a group of familial breast cancer patients and their first degree female relatives and compared to those found in normal healthy women. The ratio of BLH to the sum of ir-PRL and ir-GH was slightly but significantly decreased in the familial breast cancer group (P = 0.018 by the Mann-Whitney U test) although there were no significant differences in the levels of BLH, ir-PRL and ir-GH between the two groups. No differences in the levels of the lactogenic hormones could be detected when the pre-menopausal women were considered separately or when 20 women from the familial group were compared to normal controls matched for age, parity, weight and menopausal status. The levels of BLH were highly correlated with the sum of ir-PRL and ir-GH in both the familial breast cancer group and the controls (P less than 0.001 for both groups by Spearman's rank correlation test). These findings are not indicative of the presence of an additional species of bioactive, but not immunoreactive, lactogen in the sera of women with or at high risk of breast cancer. However, the presence of different, but equipotent, forms of lactogen cannot be excluded in these women.
Anderson
E
E
Department of Clinical Research, Christie Hospital and Holt Radium Institute, Manchester, U.K.
Morten
H
H
Wang
D Y
DY
Burns
P
P
Birch
J
J
Howell
A
A
D000293:Adolescent; D000328:Adult; D000368:Aged; D001943:Breast Neoplasms / Q000097:blood / Q000235:genetics*; D005190:Family; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D008875:Middle Aged; D011388:Prolactin / Q000097:blood*
D011388:Prolactin; D013006:Growth Hormone